{"id":6090,"date":"2012-11-08T02:01:06","date_gmt":"2012-11-08T07:01:06","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=6090"},"modified":"2012-11-08T02:01:06","modified_gmt":"2012-11-08T07:01:06","slug":"australia-asx-200-tests-support","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/","title":{"rendered":"Australia: ASX 200 tests support"},"content":{"rendered":"

The ASX 200 is testing its new support level at 4400\/4450. Reversal below 4400 would warn of a test of primary support at 4000. A 13-week Twiggs Money Flow trough above zero, however, would indicate strong buying pressure. Respect of support and follow-through above 4600 would signal an advance to 4900*.<\/p>\n

\"ASX<\/p>\n

* Target calculation: 4450 + ( 4450 – 4000 ) = 4900<\/p>\n","protected":false},"excerpt":{"rendered":"

The ASX 200 is testing its new support level at 4400\/4450. Reversal below 4400 would warn of a test of primary support at 4000. A 13-week Twiggs Money Flow trough above zero, however, would indicate strong buying pressure. Respect of support and follow-through above 4600 would signal an advance to 4900*. * Target calculation: 4450 … <\/p>\n

Continue reading “Australia: ASX 200 tests support”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[40,57],"tags":[255],"class_list":["post-6090","post","type-post","status-publish","format-standard","hentry","category-australia-nz-countries-regions","category-stock-markets","tag-asx-200-index"],"yoast_head":"\nAustralia: ASX 200 tests support - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australia: ASX 200 tests support - the patient investor\" \/>\n<meta property=\"og:description\" content=\"The ASX 200 is testing its new support level at 4400\/4450. Reversal below 4400 would warn of a test of primary support at 4000. A 13-week Twiggs Money Flow trough above zero, however, would indicate strong buying pressure. Respect of support and follow-through above 4600 would signal an advance to 4900*. * Target calculation: 4450 … Continue reading "Australia: ASX 200 tests support"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-08T07:01:06+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Australia: ASX 200 tests support\",\"datePublished\":\"2012-11-08T07:01:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\"},\"wordCount\":52,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png\",\"keywords\":[\"ASX 200 Index\"],\"articleSection\":[\"Australia & NZ\",\"Stock Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\",\"name\":\"Australia: ASX 200 tests support - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png\",\"datePublished\":\"2012-11-08T07:01:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Australia: ASX 200 tests support\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Australia: ASX 200 tests support - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Australia: ASX 200 tests support - the patient investor","og_description":"The ASX 200 is testing its new support level at 4400\/4450. Reversal below 4400 would warn of a test of primary support at 4000. A 13-week Twiggs Money Flow trough above zero, however, would indicate strong buying pressure. Respect of support and follow-through above 4600 would signal an advance to 4900*. * Target calculation: 4450 … Continue reading \"Australia: ASX 200 tests support\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2012-11-08T07:01:06+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Australia: ASX 200 tests support","datePublished":"2012-11-08T07:01:06+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/"},"wordCount":52,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png","keywords":["ASX 200 Index"],"articleSection":["Australia & NZ","Stock Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/","name":"Australia: ASX 200 tests support - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png","datePublished":"2012-11-08T07:01:06+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-11-08-xjo.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/08\/australia-asx-200-tests-support\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Australia: ASX 200 tests support"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-1Ae","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":5824,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/10\/23\/australia-asx-200-test-of-4400\/","url_meta":{"origin":6090,"position":0},"title":"Australia: ASX 200 test of 4400","author":"Colin Twiggs","date":"October 23, 2012","format":false,"excerpt":"The ASX 200 is retracing to test support at 4400\/4450. Respect would confirm a primary advance to 4900*. But correction in US markets is likely and would cause a breach of the ASX 200 rising trendline. Respect of 4250, however, would still indicate a healthy up-trend -- as would a\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":5511,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/09\/18\/australia-asx-200-rising\/","url_meta":{"origin":6090,"position":1},"title":"Australia: ASX 200 rising","author":"Colin Twiggs","date":"September 18, 2012","format":false,"excerpt":"Short bars on the S&P 500 retracement are a bullish sign, respect of short-term support at 1450 would suggest a strong advance. The ASX 200 is strengthening in sympathy, despite poor performance of Chinese markets.\u00a0 Breakout above 4400 would strengthen the primary up-trend signal, from rising 63-day Twiggs Momentum. Follow-through\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":5895,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/10\/29\/australia-asx-200-trend-channel\/","url_meta":{"origin":6090,"position":2},"title":"Australia: ASX 200 trend channel","author":"Colin Twiggs","date":"October 29, 2012","format":false,"excerpt":"The ASX 200 failed to hold on to early gains Monday. Reversal of 21-day Twiggs Money Flow below zero indicates medium-term selling pressure. Expect a test of the lower trend channel. Weakness in US or Asian markets could cause a breach of the 4400 support level, indicating a correction to\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":6140,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/13\/australia-asx-200-falls\/","url_meta":{"origin":6090,"position":3},"title":"Australia: ASX 200 falls","author":"Colin Twiggs","date":"November 13, 2012","format":false,"excerpt":"The ASX 200 broke support level at 4400, warning of a correction. Respect of medium-term support at 4250 would suggest another primary advance, while a test of primary support at 4000 would indicate an aimless market. * Target calculation: 4450 + ( 4450 - 4000 ) = 4900 A 21-day\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":5650,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/10\/03\/australia-asx-200-threatens-breakout\/","url_meta":{"origin":6090,"position":4},"title":"Australia: ASX 200 threatens breakout","author":"Colin Twiggs","date":"October 3, 2012","format":false,"excerpt":"The ASX 200 rallied off support at 4350 and is testing long-term resistance at 4450. Rising troughs on 13-week Twiggs Money Flow indicate buying pressure. Breakout above 4450 would signal a primary up-trend, with an initial target of 4900*. Reversal below the rising trendline remains as likely, because of weakness\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":5723,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/10\/09\/australia-asx-200-breakout\/","url_meta":{"origin":6090,"position":5},"title":"Australia: ASX 200 breakout","author":"Colin Twiggs","date":"October 9, 2012","format":false,"excerpt":"The ASX 200 broke through long-term resistance at 4450, signaling a primary up-trend with an initial target of 4900*. Rising troughs on 13-week Twiggs Money Flow indicate buying pressure. Retracement to test the new support level remains likely, however, in the next few weeks. * Target calculation: 4450 + (\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=6090"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6090\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=6090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=6090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=6090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}